Caris Life Sciences, Inc.

CAI

Healthcare

$19.12+0.87%vs prev close

$16.28

$42.50

52W RangeNear 52W Low

+0.10 (+0.53%)Past 1M

Price

Stock Timeline

Institutional Holders

1 Holding · 1 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Philippe LaffontCoatue Management

Increased

9,819,992

Portfolio Weight

7.56%

Est. Value

$265M

vs Prev Quarter

+11012% (88K→9.8M)

Sold · Q4 2025

Cathie WoodARK Invest

Fully Sold

Portfolio Weight

Prev Holdings

Est. Sold Value

$2K

Holding Period

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Overall Opinion

Strong Buy

Buy

Hold

Analyst Targets

avg.

$29.69

vs Current ▲ +55.3% upside

Current$19.12

Low ~ High$21.00 ~ $38.00

Firm

Position

Price Target

Upside / Downside

Close Price

Action

Date

Jefferies

Buy

$28.00

+46.48%

$19.13

Upgrade

2026-04-13

Piper Sandler

Neutral

$21.00

+9.86%

$18.05

Upgrade

2026-04-10

Evercore ISI Group

Outperform

$30.00

+56.94%

$19.01

Maintain

2026-04-06

Canaccord Genuity

Hold

$22.00

+15.09%

$18.15

Maintain

2026-03-13

Evercore ISI Group

Outperform

$34.00

+77.87%

$20.14

Maintain

2026-02-27

1 / 4

Avg Target

$29.69

vs Current ▲ +55.3% upside

Strong Buy

13 analysts

Strong Buy 1Buy 10Hold 2

Low $21.00

Current $19.12

High $38.00

Firm	Position	Target	Upside	Close	Action	Date
Jefferies	Buy	$28.00	+46.48%	$19.13	Upgrade	26.04.13
Piper Sandler	Neutral	$21.00	+9.86%	$18.05	Upgrade	26.04.10
Evercore ISI Group	Outperform	$30.00	+56.94%	$19.01	Maintain	26.04.06
Canaccord Genuity	Hold	$22.00	+15.09%	$18.15	Maintain	26.03.13
Evercore ISI Group	Outperform	$34.00	+77.87%	$20.14	Maintain	26.02.27

1 / 4

Price Information

Previous Close$18.95

Open$19.23

Day Range$18.14 - $19.27

52-Week Range$16.28 - $42.50

1-Year Change-32.32%

Trading Volume

Volume1,149,560

Avg Volume (3mo)2,239,118

Valuation

Market Cap5.4B

Book Value$2.04

Shares Outstanding282,662,545

Financials

Revenue (TTM)812.0M

Net Income-537,956,992

EPS$-3.22

EBITDA67.7M

Profitability

P/E Ratio-

P/B Ratio9.36

Return on Equity (ROE)-45.37%

Return on Assets (ROA)3.84%

Profit Margin-8.39%

EV/EBITDA73.59

Beta-

Dividend

Dividend Rate-

Dividend Yield-

Technical

RSI(14)41.47

Company Overview

Caris Life Sciences is an AI-powered TechBio company specializing in molecular profiling services for cancer treatment. Their main offerings include tissue-based (MI Profile) and blood-based (Caris Assure) molecular profiling, alongside R&D services for biopharmaceutical clients. They are also developing a multi-cancer early detection assay, positioning themselves at the forefront of precision medicine.

P/B

9.36

High valuation

ROE

-45.4%

Persistent loss

Beta

Market Volatility

RSI(14)

41.5

Neutral zone

AI-generated summary. Not investment advice.